Pharmacosmos Group has agreed to acquire commercial-stage oncology company G1 Therapeutics for $405 million. The transaction, announced Aug. 7, is expected to close late in the third quarter of 2024. Holbaek, Denmark-based Pharmacosmos was advised by Arnold & Porter Kaye Scholer. G1 Therapeutics, which is based in Research Triangle Park, North Carolina, was represented by Mintz, Levin, Cohn, Ferris, Glovsky and Popeo and a Ropes & Gray team including partners Sarah Young and Paul Kinsell. Skadden, Arps, Slate, Meagher & Flom represented Centerview Partners, which acted as financial adviser to G1 Therapeutics. The Skadden Arps team included M&A partners Christopher Barlow and Graham Robinson.
Biotech & Pharmaceuticals
August 08, 2024, 2:57 PM